TMR ANNOUNCES RESULTS OF CONCENTRACE CLINICAL TRIAL FOR OSTEOARTHRITIS SUPPORT
OGDEN, UTAH, Jan. 8, 2014Trace Minerals Research (TMR), a leading provider of trace mineral based supplements for over 40 years, announces that it has received results of a six month clinical trial on ConcenTrace® Trace Mineral Drops, its flagship ionic trace mineral supplement that is harvested from the Great Salt Lake in Utah and contains over 72 naturally-occurring trace minerals. The double-blind, placebo controlled randomized study was conducted by doctors Himanshu Bansal, Diwaker Agarwal, R. N. Srivatsava and Anupama Bansal using 100 participants with moderate osteoarthritis of the knee and is titled “Natural Mineral Supplementation Provides Chondro-Protection and Hence Improvement in Moderate Osteoarthritis of Knee.”
“This is a very important clinical trial because it shows the efficacy of ConcenTrace® for bone and joint health,” said Matt Kilts, Managing Partner of TMR. “We know that minerals and trace minerals are so important to the body because they have so many essential functions. We have had countless consumers give us testimonials of how ConcenTrace® has helped them with their bone and joint problems. Now we have the research that proves it can improve bone and joint health.”
Participants were given 40 drops of ConcenTrace® or placebo daily for 24 weeks. The study states that “efficacy was objectively confirmed by evaluating changes in the thickness of articular cartilage, joint space width and synovial fluid composition.” Results at 24 weeks state that “ultrasonography and synovial fluid examination revealed improvement in cartilage structure.”
The study also employed the Western Ontario and McMaster Universities Arthritis Index (WOMAC) and a six-minute pain free walking distance (6 MWD) as methods to determine the effectiveness of ConcenTrace®. The WOMAC is a widely used measure of a patient’s subjective assessment of pain, joint mobility and physical disability and a score is given for each dimension. After 24 weeks, the study shows that the average WOMAC score from the participants reduced from 16.2 to 7.1 and the average 6 MWD distance increased from 46 feet to 122 feet.
This preliminary study “suggests that [ConcenTrace®] improves joint health and hence increased walking distances and allows partial withdrawal of NSAIDs [non-steroidal anti-inflammatory drugs] in subjects with osteoarthritis of the knee.” The complete clinical trial results can be found on TMR’s web site at www.traceminerals.com (click here to download now).
About TMR—Trace Minerals Research (www.traceminerals.com) is the ionic mineral supplement brand you’ve known and trusted for over 40 years. TMR is the exclusive provider of ConcenTrace® Trace Mineral Drops, an ionic, solar evaporated, GRAS-affirmed and food-grade, and Non-GMO Project Verified essential trace mineral complex that is harvested from the Great Salt Lake for food, beverage and dietary supplement use. ConcenTrace® is also the number one selling trace mineral in the natural products industry. TMR uses these naturally balanced, naturally occurring minerals as the basis for all products in its branded product line. Extensive research supports the need to keep minerals in proper balance throughout the body in order to achieve optimal health. Trace Minerals Research is focused solely on servicing the natural products industry and the company’s complete line of superior quality nutritional supplements is backed by a “Feel the Difference or Your Money Back” guarantee. In addition, TMR is Good Manufacturing Practices (cGMP) certified by the Natural Products Association™ (NPA) (www.npainfo.org) under the new Food and Drug Administration’s final cGMP rule [21 CFR 111] for dietary supplements and has been GMP certified since 2004.